{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:30:50Z","timestamp":1790051450124,"version":"4.0.1"},"reference-count":170,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,13]],"date-time":"2016-08-13T00:00:00Z","timestamp":1471046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Non-coding RNA Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ncrna.2016.09.001","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T20:55:24Z","timestamp":1473454524000},"page":"51-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Non-coding RNA\/microRNA-modulatory dietary factors and natural products for improved cancer therapy and prevention: Alkaloids, organosulfur compounds, aliphatic carboxylic acids and water-soluble vitamins"],"prefix":"10.1016","volume":"1","author":[{"given":"Bernhard","family":"Biersack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncrna.2016.09.001_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/848710","article-title":"Modulation of microRNAs by phytochemicals in cancer: underlying mechanisms and translational significance","volume":"2015","author":"Srivastava","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ncrna.2016.09.001_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/07853890701771823","article-title":"MicroRNAs: a new class of gene regulators","volume":"40","author":"Guarnieri","year":"2008","journal-title":"Ann. Med."},{"key":"10.1016\/j.ncrna.2016.09.001_bib3","first-page":"383","article-title":"Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients","volume":"4","author":"Jeong","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ncrna.2016.09.001_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/1477-3163.67074","article-title":"Micro RNAs and lung cancer: biology and applications in diagnosis and prognosis","volume":"9","author":"Mallick","year":"2010","journal-title":"J.\u00a0Carcinog."},{"key":"10.1016\/j.ncrna.2016.09.001_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ab.2010.08.004","article-title":"Detection of microRNAs in dried serum blots","volume":"407","author":"Patnaik","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ncrna.2016.09.001_bib6","doi-asserted-by":"crossref","first-page":"e20980","DOI":"10.1371\/journal.pone.0020980","article-title":"Global microRNA expression profiling identifies miR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer","volume":"6","author":"Rothe","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ncrna.2016.09.001_bib7","doi-asserted-by":"crossref","first-page":"e16915","DOI":"10.1371\/journal.pone.0016915","article-title":"MiRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors","volume":"6","author":"Enerly","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ncrna.2016.09.001_bib8","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1038\/onc.2010.618","article-title":"miR-495 is upregulated by E12\/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via down-regulation of E-cadherin and REDD1","volume":"30","author":"Hwang-Verslues","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.ncrna.2016.09.001_bib9","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cell.2009.07.011","article-title":"Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells","volume":"138","author":"Shimono","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ncrna.2016.09.001_bib10","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.4161\/cc.7.20.6851","article-title":"MicroRNAs as regulators of epithelial-mesenchymal transition","volume":"7","author":"Gregory","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ncrna.2016.09.001_bib11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1074\/jbc.M111.280768","article-title":"MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells","volume":"287","author":"Yu","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ncrna.2016.09.001_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartels","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ncrna.2016.09.001_bib13","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1038\/onc.2010.34","article-title":"Multiple microRNAs modulate p21Cip1\/Waf1 expression by directly targeting its 3\u2032 untranslated region","volume":"29","author":"Wu","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ncrna.2016.09.001_bib14","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ncrna.2016.09.001_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"MicroRNAs in cancer","volume":"9","author":"di Leva","year":"2014","journal-title":"Ann. Rev. Pathol."},{"key":"10.1016\/j.ncrna.2016.09.001_bib16","first-page":"255","article-title":"Regulation of microRNAs in cancer metastasis","volume":"22","author":"Bouyssou","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ncrna.2016.09.001_bib17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd4140","article-title":"MicroRNAs and other non-coding RNAs as targets for anticancer drug development","volume":"12","author":"King","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ncrna.2016.09.001_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ncrna.2016.07.001","article-title":"Current state of phenolic and terpenoidal dietary factors and natural products as non-coding RNA\/microRNA modulators for improved cancer therapy and prevention","volume":"1","author":"Biersack","year":"2016","journal-title":"Non-coding RNA Res."},{"key":"10.1016\/j.ncrna.2016.09.001_bib19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1146\/annurev.arplant.59.032607.092730","article-title":"Alkaloid biosynthesis: metabolism and trafficking","volume":"59","author":"Ziegler","year":"2008","journal-title":"Ann. Rev. Plant Biol."},{"key":"10.1016\/j.ncrna.2016.09.001_bib20","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1158\/1078-0432.CCR-04-0163","article-title":"Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice","volume":"10","author":"Anderton","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ncrna.2016.09.001_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201500867","article-title":"The bounty of nature for changing the cancer landscape","author":"Ahmad","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ncrna.2016.09.001_bib22","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2174\/18715206113139990078","article-title":"Targeted regulation of PI3K\/Akt\/mTOR\/NF-kB signaling by indole compounds and their derivatives: mechanistic details and biological implications for cancer therapy","volume":"13","author":"Ahmad","year":"2013","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"10.1016\/j.ncrna.2016.09.001_bib23","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ctrv.2009.07.001","article-title":"Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics","volume":"35","author":"Sarkar","year":"2009","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ncrna.2016.09.001_bib24","doi-asserted-by":"crossref","first-page":"e33729","DOI":"10.1371\/journal.pone.0033729","article-title":"Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM","volume":"7","author":"Kong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ncrna.2016.09.001_bib25","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1158\/0008-5472.CAN-09-2792","article-title":"MiR-146a suppresses invasion of pancreatic cancer cells","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ncrna.2016.09.001_bib26","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-09-1298","article-title":"Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells","volume":"69","author":"Li","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ncrna.2016.09.001_bib27","doi-asserted-by":"crossref","first-page":"e54657","DOI":"10.1371\/journal.pone.0054657","article-title":"3,3\u2032-Diindolylmethane enhances the effectiveness of Herceptin against HER-2\/neu-expressing breast cancer cells","volume":"8","author":"Ahmad","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ncrna.2016.09.001_bib28","first-page":"432","article-title":"Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness","volume":"4","author":"Kashat","year":"2012","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ncrna.2016.09.001_bib29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12943-015-0443-9","article-title":"Aryl hydrocarbon receptor-micrRNA-212\/132 axis in human breast cancer suppresses metastasis by targeting SOX4","volume":"14","author":"Hanieh","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ncrna.2016.09.001_bib30","first-page":"1473","article-title":"Chemosensitivity induced by down-regulation of microRNA-21 in gemcitabine-resistant pancreatic cancer cells by indole-3-carbinol","volume":"33","author":"Paik","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ncrna.2016.09.001_bib31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/carcin\/bgp208","article-title":"Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol","volume":"31","author":"Melkamu","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ncrna.2016.09.001_bib32","first-page":"465","article-title":"Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA","volume":"3","author":"Sarkar","year":"2013","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ncrna.2016.09.001_bib33","doi-asserted-by":"crossref","first-page":"e33011","DOI":"10.1371\/journal.pone.0033011","article-title":"Targeting bone remodeling by isoflavone and 3,3\u2032-diindolylmethane in the context of prostate cancer bone metastasis","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ncrna.2016.09.001_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11010-011-0985-0","article-title":"3,3\u2032-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated CDC25A degradation","volume":"358","author":"Jin","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ncrna.2016.09.001_bib35","first-page":"1390","article-title":"The vinca alkaloids: a new class of oncolytic agents","volume":"23","author":"Johnson","year":"1963","journal-title":"Cancer Res."},{"key":"10.1016\/j.ncrna.2016.09.001_bib36","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bcp.2008.06.007","article-title":"Role of microRNA miR-27a and miR-451 in the regulation of MDR1\/P-glycoprotein expression in human cancer cells","volume":"76","author":"Zhu","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ncrna.2016.09.001_bib37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/bdd.764","article-title":"MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines","volume":"32","author":"Rodrigues","year":"2011","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ncrna.2016.09.001_bib38","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4161\/auto.27418","article-title":"MIR34A regulates autophagy and apoptosis by targeting HMGB1 in the retinoblastoma cell","volume":"10","author":"Liu","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.ncrna.2016.09.001_bib39","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3892\/or.2012.2155","article-title":"Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines","volume":"29","author":"Zhuo","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ncrna.2016.09.001_bib40","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1590\/1414-431X20131662","article-title":"Identification of microRNAs and mRNAs associated with multidrug resistance of human laryngeal cancer Hep-2 cells","volume":"46","author":"Yin","year":"2013","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ncrna.2016.09.001_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1475-2867-13-21","article-title":"MiR-125b develops chemoresistance in Ewing sarcoma\/primitive neuroectodermal tumor","volume":"13","author":"Iida","year":"2013","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ncrna.2016.09.001_bib42","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1568009614666140818211103","article-title":"Deregulated expression of miR-224 and its target gene: CD59 predicts outcome of diffuse large B-cell lymphoma patients treated with R-CHOP","volume":"14","author":"Song","year":"2014","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ncrna.2016.09.001_bib43","doi-asserted-by":"crossref","first-page":"18077","DOI":"10.3390\/ijms160818077","article-title":"MiR-199a and miR-497 are associated with better overall survival due to increased chemosensitivity in diffuse large B-cell lymphoma patients","volume":"16","author":"Troppan","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ncrna.2016.09.001_bib44","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.4161\/rna.26541","article-title":"A\u00a0high-throughput screen identifies miRNA inhibitors regulating lung cancer cell survival and response to paclitaxel","volume":"10","author":"Du","year":"2013","journal-title":"RNA Biol."},{"key":"10.1016\/j.ncrna.2016.09.001_bib45","doi-asserted-by":"crossref","first-page":"19601","DOI":"10.18632\/oncotarget.7481","article-title":"MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes","volume":"7","author":"Zhong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2016.09.001_bib46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.gene.2014.11.046","article-title":"MicroRNA expression profiling and bioinformatics analysis of dysregulated microRNAs in vinorelbine-resistant breast cancer cells","volume":"556","author":"Zhong","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.ncrna.2016.09.001_bib47","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.lungcan.2013.07.020","article-title":"Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin vinorelbine A ELCWP prospective study","volume":"82","author":"Berghmans","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ncrna.2016.09.001_bib48","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrd2871","article-title":"Factors underlying sensitivity of cancers to small-molecule kinase inhibitors","volume":"8","author":"J\u00e4nne","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ncrna.2016.09.001_bib49","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1074\/jbc.M112.414128","article-title":"MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C \u03b5 (PKC\u03b5)","volume":"288","author":"K\u00f6rner","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ncrna.2016.09.001_bib50","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cub.2007.06.068","article-title":"p53-mediated activation of miRNA34 candidate tumor-suppressor genes","volume":"17","author":"Bommer","year":"2007","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ncrna.2016.09.001_bib51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1476-4598-9-211","article-title":"MiR-145, a new regulator of the DNA fragmentation factor-45 (DFF45)-mediated apoptotic network","volume":"9","author":"Zhang","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ncrna.2016.09.001_bib52","doi-asserted-by":"crossref","first-page":"21505","DOI":"10.1073\/pnas.1016218107","article-title":"MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets","volume":"107","author":"Ooi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ncrna.2016.09.001_bib53","doi-asserted-by":"crossref","first-page":"e9429","DOI":"10.1371\/journal.pone.0009429","article-title":"MiR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells","volume":"5","author":"Qin","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ncrna.2016.09.001_bib54","first-page":"228","article-title":"Isolation of new fractions of antitumor mitomycins","volume":"8","author":"Wakaki","year":"1958","journal-title":"Antibiot. Chemother."},{"key":"10.1016\/j.ncrna.2016.09.001_bib55","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1073\/pnas.50.2.355","article-title":"A\u00a0molecular mechanism of mitomycin action: linking of complementary DNA strands","volume":"50","author":"Iyer","year":"1963","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ncrna.2016.09.001_bib56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0163-7258(97)00088-0","article-title":"The mitomycin bioreductive antitumor agents: cross-linking and alkylation of DNA as the molecular basis of their activity","volume":"76","author":"Tomasz","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ncrna.2016.09.001_bib57","article-title":"MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin \u03b15","author":"Xu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2016.09.001_bib58","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1134\/S1022795414080092","article-title":"Inheritable changes in miRNAs expression in HeLa cells after x-ray and mitomycin C treatment","volume":"50","author":"Tarasov","year":"2014","journal-title":"Russ. J. Gen."},{"key":"10.1016\/j.ncrna.2016.09.001_bib59","first-page":"753","article-title":"Camptothecin and taxol: discovery to clinic \u2013 thirteenth Bruce F. Cain Memorial Award lecture","volume":"55","author":"Wall","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.ncrna.2016.09.001_bib60","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1517\/13543784.13.3.269","article-title":"Camptothecins in clinical development","volume":"13","author":"Zunino","year":"2004","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"10.1016\/j.ncrna.2016.09.001_bib61","doi-asserted-by":"crossref","first-page":"15387","DOI":"10.1073\/pnas.242259599","article-title":"The mechanism of topoisomerase I poisoning by a camptothecin analog","volume":"99","author":"Staker","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ncrna.2016.09.001_bib62","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1124\/mol.111.076794","article-title":"Camptothecin induces apoptosis in cancer cells via micro-RNA-125b-mediated mitochondrial pathways","volume":"81","author":"Zeng","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ncrna.2016.09.001_bib63","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/15384047.2015.1040963","article-title":"MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of camptothecin","volume":"16","author":"Huang","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ncrna.2016.09.001_bib64","first-page":"4316","article-title":"Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway","volume":"62","author":"Rapisarda","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ncrna.2016.09.001_bib65","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1158\/1535-7163.MCT-13-0729","article-title":"The natural inhibitor of DNA topoisomerase I, camptothecin, modulates HIF-1\u03b1 activity by changing miR expression patterns in human cancer cells","volume":"13","author":"Bertozzi","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ncrna.2016.09.001_bib66","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/stem.741","article-title":"MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells","volume":"29","author":"Bitarte","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.ncrna.2016.09.001_bib67","first-page":"744","article-title":"Circulating and tumor miR-21 could predict irinotecan sensitivity in gastric cancer","volume":"23","author":"Xu","year":"2013","journal-title":"Zhongguo Aizheng Zazhi"},{"key":"10.1016\/j.ncrna.2016.09.001_bib68","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.yexcr.2015.09.011","article-title":"Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer","volume":"338","author":"To","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ncrna.2016.09.001_bib69","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1476-4598-12-119","article-title":"MiR-23a-mediated inhibition of topoisomerase 1 expression potentiates cell response to etoposide in human hepatocellular carcinoma","volume":"12","author":"Wang","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ncrna.2016.09.001_bib70","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/tpj.2010.58","article-title":"Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan","volume":"11","author":"Boni","year":"2011","journal-title":"Pharmacogen. J."},{"key":"10.1016\/j.ncrna.2016.09.001_bib71","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1634\/theoncologist.2012-0081","article-title":"High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease","volume":"17","author":"Ruzzo","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.ncrna.2016.09.001_bib72","doi-asserted-by":"crossref","first-page":"e99886","DOI":"10.1371\/journal.pone.0099886","article-title":"MiR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and irinotecan","volume":"9","author":"Schou","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ncrna.2016.09.001_bib73","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1158\/1535-7163.MCT-10-0674","article-title":"Genome-wide mRNA and microRNA profiling of the NCI 60 cell-line screen and comparison of FdUMP[10] with fluorouracil, floxuridine, and topoisomerase 1 poisons","volume":"9","author":"Gmeiner","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ncrna.2016.09.001_bib74","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1373\/clinchem.2010.150730","article-title":"Intracellular and extracellular microRNAs in breast cancer","volume":"57","author":"Corcoran","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ncrna.2016.09.001_bib75","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ygyno.2009.01.014","article-title":"MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy","volume":"113","author":"Boren","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ncrna.2016.09.001_bib76","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1039\/C4NP00051J","article-title":"Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics","volume":"32","author":"Le","year":"2015","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ncrna.2016.09.001_bib77","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1158\/1535-7163.MCT-08-0848","article-title":"Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors","volume":"8","author":"Forni","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ncrna.2016.09.001_bib78","doi-asserted-by":"crossref","first-page":"e35423","DOI":"10.1371\/journal.pone.0035423","article-title":"A\u00a0systems biology approach to characterize the regulatory networks leading to trabectedin resistance in an in\u00a0vitro model of myxoid liposarcoma","volume":"7","author":"Uboldi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ncrna.2016.09.001_bib79","doi-asserted-by":"crossref","first-page":"12349","DOI":"10.3390\/molecules190812349","article-title":"Berberine, an epiphany against cancer","volume":"19","author":"Ortiz","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ncrna.2016.09.001_bib80","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/aps.2012.161","article-title":"Set9, NF-\u03baB, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells","volume":"34","author":"Hu","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ncrna.2016.09.001_bib81","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1752-0509-8-82","article-title":"Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine","volume":"8","author":"Luo","year":"2014","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.ncrna.2016.09.001_bib82","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/abbs\/gmt075","article-title":"Berberine sensitizes ovarian cancer cells to cisplatin through miR-21\/PDCD4 axis","volume":"45","author":"Liu","year":"2013","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.ncrna.2016.09.001_bib83","doi-asserted-by":"crossref","first-page":"e75628","DOI":"10.1371\/journal.pone.0075628","article-title":"MicroRNA-21\u20133p, a berberine-induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth","volume":"8","author":"Lo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ncrna.2016.09.001_bib84","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/15476286.2015.1017219","article-title":"Systematic analysis of berberine-induced signaling pathway between miRNA clusters and mRNAs and identification of mir-99a\u223c125b cluster function by seed-targeting inhibitors in multiple myeloma cells","volume":"12","author":"Feng","year":"2015","journal-title":"RNA Biol."},{"key":"10.1016\/j.ncrna.2016.09.001_bib85","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1021\/jf020674o","article-title":"Rat lens aldose reductase inhibitory activities of Coptis japonica root-derived isoquinoline alkaloids","volume":"50","author":"Lee","year":"2002","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.ncrna.2016.09.001_bib86","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/mc.22192","article-title":"Palmatine inhibits growth and invasion in prostate cancer cell: potential role for rpS6\/NFkB\/FLIP","volume":"54","author":"Hambright","year":"2014","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ncrna.2016.09.001_bib87","doi-asserted-by":"crossref","first-page":"14697","DOI":"10.1038\/srep14697","article-title":"A\u00a0robust screening method for dietary agents that activate tumour-suppressor microRNAs","volume":"5","author":"Hagiwara","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ncrna.2016.09.001_bib88","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1159\/000341444","article-title":"Matrine inhibits breast cancer growth via miR-21\/PTEN\/Akt pathway in MCF-7 cells","volume":"30","author":"Li","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ncrna.2016.09.001_bib89","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.3892\/or_xxxxxxxx","article-title":"Matrine alters microRNA expression profiles in SGC-7901 human gastric cancer cells","volume":"32","author":"Li","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ncrna.2016.09.001_bib90","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.2174\/138945011798184155","article-title":"Cancer chemoprevention by targeting the epigenome","volume":"12","author":"Huang","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ncrna.2016.09.001_bib91","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/em.20454","article-title":"Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulphoraphane and garlic organosulfur compounds","volume":"50","author":"Nian","year":"2009","journal-title":"Environ. Mol. Mutagen"},{"key":"10.1016\/j.ncrna.2016.09.001_bib92","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.canlet.2008.05.027","article-title":"Multitargeted prevention and therapy of cancer by diallyl trisulfide and related Allium vegetable-derived organosulfur compounds","volume":"269","author":"Powolny","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ncrna.2016.09.001_bib93","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1207\/S15327914NC431_11","article-title":"Induction of histone acetylation and inhibition of growth of mouse erythroleukemia cells by S-allylmercaptocysteine","volume":"43","author":"Lea","year":"2002","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.ncrna.2016.09.001_bib94","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/carcin\/bgn165","article-title":"Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter","volume":"29","author":"Nian","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ncrna.2016.09.001_bib95","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.canlet.2013.06.027","article-title":"Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22","volume":"340","author":"Tang","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ncrna.2016.09.001_bib96","doi-asserted-by":"crossref","first-page":"e112720","DOI":"10.1371\/journal.pone.0112720","article-title":"Diallyl disulfide suppresses SRC\/Ras\/ERK signaling-mediated proliferation and metastasis in human breast cancer by up-regulating miR-34a","volume":"9","author":"Xiao","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ncrna.2016.09.001_bib97","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.3892\/ol.2016.4266","article-title":"Upregulation of miR-34a by diallyl disulfide suppresses invasion and induces apoptosis in SGC-7901 cells through inhibition of the PI3K\/Akt signaling pathway","volume":"11","author":"Wang","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ncrna.2016.09.001_bib98","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1745-7254.2007.00679.x","article-title":"Discovery and development of sulforaphane as a cancer chemopreventive phytochemical","volume":"28","author":"Zhang","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ncrna.2016.09.001_bib99","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/MCO.0b013e328362014e","article-title":"Epigenetic impact of dietary isothiocyanates in cancer chemoprevention","volume":"16","author":"Gerhauser","year":"2013","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.ncrna.2016.09.001_bib100","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jnutbio.2012.08.004","article-title":"Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2\/MMP2\/Snail, ZEB1 and miR-200c\/ZEB1 pathways in human bladder cancer cells","volume":"24","author":"Shan","year":"2013","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.ncrna.2016.09.001_bib101","article-title":"Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction","author":"Liu","year":"2016","journal-title":"J.\u00a0Formos. Med. Assoc."},{"key":"10.1016\/j.ncrna.2016.09.001_bib102","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1038\/onc.2013.226","article-title":"Down-regulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer","volume":"33","author":"Li","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.ncrna.2016.09.001_bib103","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3892\/ijo.2014.2539","article-title":"Sulforaphane, quercetin and catechins complement each other in elimination of advanced pancreatic cancer by miR-let-7 induction and K-ras inhibition","volume":"45","author":"Appari","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ncrna.2016.09.001_bib104","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/01635581.2013.756530","article-title":"Identification of microRNAs regulated by isothiocyanates and association of polymorphisms inside their target sites with risk of sporadic colorectal cancer","volume":"65","author":"Slaby","year":"2013","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.ncrna.2016.09.001_bib105","first-page":"375","article-title":"De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc","volume":"33","author":"Wang","year":"2008","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ncrna.2016.09.001_bib106","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/pros.22501","article-title":"miR-141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein","volume":"72","author":"Xiao","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.ncrna.2016.09.001_bib107","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1158\/1940-6207.CAPR-09-0202","article-title":"Chemoprevention of cigarette smoke-induced alterations of microRNA expression in rat lungs","volume":"3","author":"Izzotti","year":"2010","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.ncrna.2016.09.001_bib108","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ddr.21268","article-title":"Impact of histone deacetylase inhibitors on microRNA expression and cancer therapy: a review","volume":"76","author":"Ali","year":"2015","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ncrna.2016.09.001_bib109","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/S0021-9258(17)37831-6","article-title":"Different accessibilities in chromatin to histone acetylase","volume":"254","author":"Cousens","year":"1979","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ncrna.2016.09.001_bib110","doi-asserted-by":"crossref","first-page":"e16221","DOI":"10.1371\/journal.pone.0016221","article-title":"The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer","volume":"6","author":"Hu","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ncrna.2016.09.001_bib111","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12263-015-0500-4","article-title":"Influence of miRNA-106b and miRNA-135a on butyrate-regulated expression of p21 and cyclin D2 in human colon adenoma cells","volume":"10","author":"Schl\u00f6rmann","year":"2015","journal-title":"Genes Nutr."},{"key":"10.1016\/j.ncrna.2016.09.001_bib112","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11010-013-1762-z","article-title":"Histone deacetylase inhibitor trichostatin A increases the expression of Dleu2\/miR-15a\/16-1 via HDAC3 in non-small cell lung cancer","volume":"383","author":"Chen","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ncrna.2016.09.001_bib113","first-page":"983","article-title":"Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K\/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101","volume":"93","author":"Ferreira","year":"2014","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ncrna.2016.09.001_bib114","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/mt.2014.247","article-title":"HDAC inhibitors target HDAC5, upregulate microRNA-125-5p, and induce apoptosis in breast cancer cells","volume":"23","author":"Hsieh","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ncrna.2016.09.001_bib115","doi-asserted-by":"crossref","first-page":"10555","DOI":"10.1074\/jbc.M114.624361","article-title":"MicroRNA-31 is a transcriptional target of histone deacetylase inhibitors and a regulator of cellular senescence","volume":"290","author":"Cho","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ncrna.2016.09.001_bib116","first-page":"2142","article-title":"A\u00a0phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies","volume":"8","author":"Patnaik","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ncrna.2016.09.001_bib117","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00280-003-0580-5","article-title":"Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug","volume":"51","author":"Edelman","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ncrna.2016.09.001_bib118","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.biochi.2012.05.012","article-title":"Chromatin-modifying agents in anti-cancer therapy","volume":"94","author":"Seidel","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.ncrna.2016.09.001_bib119","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/43710","article-title":"Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors","volume":"401","author":"Finnin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ncrna.2016.09.001_bib120","doi-asserted-by":"crossref","first-page":"e45133","DOI":"10.1371\/journal.pone.0045133","article-title":"TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ncrna.2016.09.001_bib121","doi-asserted-by":"crossref","first-page":"168949","DOI":"10.1155\/2014\/168949","article-title":"Trichostatin A suppresses EGFR expression through induction of microRNA-7 in an HDAC-independent manner in lapatinib-treated cells","volume":"2014","author":"Tu","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ncrna.2016.09.001_bib122","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/mt.2014.247","article-title":"HDAC inhibitors target HDAC5, upregulate microRNA-125a-5p, and induce apoptosis in breast cancer cells","volume":"23","author":"Hsieh","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ncrna.2016.09.001_bib123","first-page":"10","article-title":"The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells","volume":"27","author":"Rhodes","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ncrna.2016.09.001_bib124","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11010-013-1762-z","article-title":"Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2\/miR-15a\/16-1 via HDAC 3 in non-small cell lung cancer","volume":"383","author":"Chen","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ncrna.2016.09.001_bib125","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.canlet.2014.07.019","article-title":"Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes","volume":"353","author":"Seol","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ncrna.2016.09.001_bib126","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1038\/onc.2011.470","article-title":"Myc represses miR-15a\/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas","volume":"31","author":"Zhang","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.ncrna.2016.09.001_bib127","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1053\/j.gastro.2012.05.033","article-title":"Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells","volume":"143","author":"Buurman","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ncrna.2016.09.001_bib128","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1530\/ERC-10-0257","article-title":"MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells","volume":"18","author":"Brest","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ncrna.2016.09.001_bib129","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/jcb.25039","article-title":"Anti-cancer drugs reactivate tumor suppressor miR-375 expression in tongue cancer cells","volume":"116","author":"Jung","year":"2015","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.ncrna.2016.09.001_bib130","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1038\/onc.2012.483","article-title":"MiR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer","volume":"32","author":"Su","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ncrna.2016.09.001_bib131","first-page":"161","article-title":"MicroRNA-449a\/b inhibits the expression of Fra-1 in human colon cancer cells","volume":"29","author":"Wu","year":"2013","journal-title":"Zhongguo Shengwu Huaxue Yu Fenzi Shengwu Xuebao"},{"key":"10.1016\/j.ncrna.2016.09.001_bib132","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000186051","article-title":"Epigenetic silencing of microRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer","volume":"9","author":"Lee","year":"2009","journal-title":"Pancreatology"},{"key":"10.1016\/j.ncrna.2016.09.001_bib133","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10120-014-0340-8","article-title":"DNA methylation downregulated miR-10b acts as a tumor suppressor in gastric cancer","volume":"18","author":"Li","year":"2015","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ncrna.2016.09.001_bib134","doi-asserted-by":"crossref","first-page":"e60369","DOI":"10.1371\/journal.pone.0060369","article-title":"MicroRNA-219-2-3p functions as a tumor suppressor in gastric cancer and is regulated by DNA methylation","volume":"8","author":"Lei","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ncrna.2016.09.001_bib135","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/jcb.25110","article-title":"Upregulation of miR-362-3p modulates proliferation and anchorage-independent growth by directly targeting Tob2 in hepatocellular carcinoma","volume":"116","author":"Shen","year":"2015","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.ncrna.2016.09.001_bib136","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1158\/0008-5472.CAN-07-6655","article-title":"Methylation mediated silencing of microRNA-1 gene and its role in hepatocellular carcinogenesis","volume":"68","author":"Datta","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ncrna.2016.09.001_bib137","first-page":"1849","article-title":"MiR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer","volume":"7","author":"Letelier","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ncrna.2016.09.001_bib138","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s11102-014-0630-5","article-title":"Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells","volume":"18","author":"Kitchen","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.ncrna.2016.09.001_bib139","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/jn\/123.suppl_2.418","article-title":"Colon cancer \u2013 do the nutritional epidemiology, the gut physiology and the molecular biology tell the same story","volume":"123","author":"Potter","year":"1993","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.ncrna.2016.09.001_bib140","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/jn\/128.3.491","article-title":"Fish oil blocks azoxymethane-induced rat colon tumorigenesis by increasing cell differentiation and apoptosis rather than decreasing cell proliferation","volume":"128","author":"Chang","year":"1998","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.ncrna.2016.09.001_bib141","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/1055-9965.EPI-07-2803","article-title":"A\u00a022-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men","volume":"17","author":"Hall","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ncrna.2016.09.001_bib142","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/gut.2009.200642","article-title":"Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis","volume":"59","author":"West","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.ncrna.2016.09.001_bib143","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/carcin\/bgp245","article-title":"n-3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon","volume":"30","author":"Davidson","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ncrna.2016.09.001_bib144","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1476-511X-10-173","article-title":"MicroRNA profile of polyunsaturated fatty acid treated glioma cells reveal apoptosis-specific expression changes","volume":"10","author":"Farag\u00f3","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ncrna.2016.09.001_bib145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12943-015-0400-7","article-title":"Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA)","volume":"14","author":"Hannafon","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ncrna.2016.09.001_bib146","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/carcin\/bgs198","article-title":"MiR-21 is targeted by omega-3 polyunsaturated fatty acid to regulate breast tumor CSF-1 expression","volume":"33","author":"Mandal","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ncrna.2016.09.001_bib147","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jnutbio.2015.02.009","article-title":"Dietary walnut suppression of colorectal cancer in mice: mediation by miRNA patterns and fatty acid incorporation","volume":"26","author":"Tsoukas","year":"2015","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.ncrna.2016.09.001_bib148","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3945\/an.111.000992","article-title":"Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role","volume":"3","author":"Crider","year":"2012","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.ncrna.2016.09.001_bib149","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1111\/j.1753-4887.2008.00064.x","article-title":"Differential expression of microRNAs during hepatocarcinogenesis induced by methyl deficiency in rats","volume":"66","author":"Pogribny","year":"2008","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.ncrna.2016.09.001_bib150","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcb.20982","article-title":"Downregulation of miR-122 in the rodent and human hepatocellular carcinomas","volume":"99","author":"Kutay","year":"2006","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.ncrna.2016.09.001_bib151","doi-asserted-by":"crossref","first-page":"10843","DOI":"10.1158\/0008-5472.CAN-06-1894","article-title":"MicroRNA responses to cellular stress","volume":"66","author":"Marsit","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ncrna.2016.09.001_bib152","doi-asserted-by":"crossref","first-page":"19016","DOI":"10.1021\/acsami.5b06206","article-title":"MicroRNA-responsive cancer cell imaging and therapy with functionalized gold nanoprobe","volume":"7","author":"Liu","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ncrna.2016.09.001_bib153","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/adfm.201504912","article-title":"Folic-acid-mediated functionalized gold nanocages for targeted delivery of anti-miR-181b in combination of gene therapy and photothermal therapy against hepatocellular carcinoma","volume":"26","author":"Huang","year":"2016","journal-title":"Adv. Funct. Matter"},{"key":"10.1016\/j.ncrna.2016.09.001_bib154","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0009-2797(74)90019-2","article-title":"The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer","volume":"9","author":"Cameron","year":"1974","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ncrna.2016.09.001_bib155","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1073\/pnas.73.10.3685","article-title":"Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer","volume":"73","author":"Cameron","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ncrna.2016.09.001_bib156","first-page":"263","article-title":"Vitamin C in complementary oncology - update 2009","volume":"32","author":"Gr\u00f6ber","year":"2009","journal-title":"Med. Monatsschr. Pharm."},{"key":"10.1016\/j.ncrna.2016.09.001_bib157","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM198501173120301","article-title":"High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy: a randomized double-blind comparison","volume":"312","author":"Moertel","year":"1985","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ncrna.2016.09.001_bib158","doi-asserted-by":"crossref","first-page":"13604","DOI":"10.1073\/pnas.0506390102","article-title":"Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as prodrug to deliver hydrogen peroxide to tissues","volume":"102","author":"Chen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ncrna.2016.09.001_bib159","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/07315724.2003.10719284","article-title":"The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer","volume":"22","author":"Drisko","year":"2003","journal-title":"J.\u00a0Am. Coll. Nutr."},{"key":"10.1016\/j.ncrna.2016.09.001_bib160","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0306-9877(95)90137-X","article-title":"Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent","volume":"44","author":"Riodan","year":"1995","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ncrna.2016.09.001_bib161","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1503\/cmaj.050346","article-title":"Intravenously administered vitamin C as cancer therapy: three cases","volume":"174","author":"Padayatty","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.ncrna.2016.09.001_bib162","article-title":"Hochdosis-Infusionstherapie mit Vitamin C in der adjuvanten Therapie des Mammakarzinoms","volume":"12","author":"Brascho\u00df","year":"2006","journal-title":"Onkologie"},{"key":"10.1016\/j.ncrna.2016.09.001_bib163","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2007-968114","article-title":"Vitamin-C-Hochdosisinfusionstherapie bei Mammakarzinom","volume":"39","author":"Gr\u00f6ber","year":"2007","journal-title":"Dtsch. Z. Onkol."},{"key":"10.1016\/j.ncrna.2016.09.001_bib164","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/1534735414534463","article-title":"Intravenous vitamin C and cancer: a systematic review","volume":"13","author":"Fritz","year":"2014","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.ncrna.2016.09.001_bib165","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00280-013-2070-8","article-title":"Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial","volume":"71","author":"Welsh","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ncrna.2016.09.001_bib166","first-page":"104","article-title":"Mikron\u00e4hrstoffe: vitamin C \u2013 aktuell und kompakt","volume":"148","author":"Gr\u00f6ber","year":"2008","journal-title":"Dtsch. Apoth. Ztg"},{"key":"10.1016\/j.ncrna.2016.09.001_bib167","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/jcmm.12207","article-title":"The ROS-induced cytotoxicity of ascorbate is attenuated by hypoxia and HIF-1alpha in the NCI60 cancer cell lines","volume":"18","author":"Sinnberg","year":"2014","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.ncrna.2016.09.001_bib168","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/carcin\/bgt026","article-title":"MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis","volume":"34","author":"Singh","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ncrna.2016.09.001_bib169","doi-asserted-by":"crossref","first-page":"39","DOI":"10.7754\/Clin.Lab.2015.150518","article-title":"MicroRNA-153 regulates NRF2 expression and is associated with breast carcinogenesis","volume":"62","author":"Wang","year":"2016","journal-title":"Clin. Lab."},{"key":"10.1016\/j.ncrna.2016.09.001_bib170","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2014.00227","article-title":"Epigenetic impacts of ascorbate on human metastatic melanoma cells","volume":"4","author":"Venturelli","year":"2014","journal-title":"Front. Oncol."}],"container-title":["Non-coding RNA Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054016300051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054016300051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T02:14:33Z","timestamp":1657246473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468054016300051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":170,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S2468054016300051"],"URL":"https:\/\/doi.org\/10.1016\/j.ncrna.2016.09.001","relation":{},"ISSN":["2468-0540"],"issn-type":[{"value":"2468-0540","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-coding RNA\/microRNA-modulatory dietary factors and natural products for improved cancer therapy and prevention: Alkaloids, organosulfur compounds, aliphatic carboxylic acids and water-soluble vitamins","name":"articletitle","label":"Article Title"},{"value":"Non-coding RNA Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncrna.2016.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}